05 December 2013
NovaMedica LLC, a Russian pharmaceutical company, has signed a partnership agreement with Aptalis Pharma, a leading specialty pharmaceutical company, providing innovative, effective therapies for unmet medical needs, to develop and commercialize a portfolio of three of Aptalis Pharma’s novel gastrointestinal pharmaceutical products in Russia.
05 November 2013
NovaMedica is expected to launch its first portfolio products in H1 2014 and own developments are expected to launch in 1,5-2 years, - said Vladimir Gurdus, CEO of D-Pharma, Management Company of RusnanoMedInvest LLC and NovaMedica LLC at Pharma Russia Conference hosted by the newspaper “Vedomosti”.
31 July 2013
NovaMedica, a Russian pharmaceutical and medical device company, and ReVision Optics, Inc. the U.S. developer of the innovative refractive surgery solution against presbyopia Raindrop™ Near Vision Corneal Inlay, have signed an agreement to commercialize this technology in Russia.
NovaMedica, Kaluga Region and City of Kaluga Sign Agreement on Construction of Pharmaceutical Plant
25 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
24 June 2013
Leonid Melamed, Chairman of the Board of Directors, Team Drive, and Member of the Board of Directors, RusnanoMedInvest and NovaMedica: The environment must be designed for delivering ideas and people for innovations; this objective and KPI of the Ministry of Education could be achieved through joining of several Russian universities the top 100 world universities".
24 June 2013
During SPIEF 2013 panel “Knowledge-based economy – a strategy for getting ahead of the curve”, one of the moderators of which was Leonid Melamed (Member of the Board of Directors, RusnanoMedInvest and NovaMedica; Chairman of the Board of Directors, Team Drive), the panelists featuring science, education, government and investment banking have shared their views on the viability and prospects for further development of the knowledge-based economy in Russia as the highest stage in the development of innovative economy putting together specific proposals/ideas in favor of their viewpoints.
24 June 2013
Leonid Melamed, Chairman of the Board of Directors, Team Drive; Member of the Board of Directors, RosnanoMedInvest an NovaMedica: "The State policy shall be focused on having as much elements in the pharmaceutical value creation chain concentrated in the hands of as many Russia-based companies paying taxes in Russia as possible."
03 June 2013
S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation on localization of innovative ophthalmic products and technologies sourced from around the globe to be developed and produced in Russia.
25 April 2013
New pharmaceutical company NovaMedica is an integral part of this Russian Government’s Healthcare strategy within “Russia 2020” that will boost growth in the Pharmaceutical Market for the next 10 years.
Announce: Novamedica on BIO 2013: Spotlight On The BRICs. Russia
19 April 2013
BIO International Convention (BIO-2013). Chicago, USA. Special session «Spotlight on the BRICs: Russia» Monday, Apr 22, 2013
October 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
Federal Center for Animal Health develops 13 new veterinary vaccines
22 October 2024
Haemophilia treatment with new delivery method approved
22 October 2024
Immunotherapy treatment enhances lymphoma survival, landmark study shows
21 October 2024
The Russian Ministry of Health initiates the creation of a list of key drugs
21 October 2024